(Q34351253)

1 August 2017

title

Therapy-related acute promyelocytic leukemia: a systematic review (English)

1 reference

acute promyelocytic leukemia

1 August 2017

1 reference

1 reference

1 reference

Armin Rashidi

1

1 reference

1 August 2017

Stephen I Fisher

series ordinal

2

1 reference

1 August 2017

publication date

15 June 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

625

1 reference

Clinical and pathologic features of secondary acute promyelocytic leukemia

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Uncommon presentations of some common malignancies: Case 2. Nasopharyngeal carcinoma followed by secondary acute promyelocytic leukemia presenting with respiratory distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported i

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Biology and therapy of secondary leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Secondary acute promyelocytic leukemia following chemotherapy for non-Hodgkin's lymphoma in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Prognosis and therapy when acute promyelocytic leukemia and other "good risk" acute myeloid leukemias occur as a therapy-related myeloid neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Acute leukaemia in patients treated for Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Acute myeloid leukemia following treatment of Hodgkin's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

A case report of acute myeloid leukemia after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Leukemia after liver transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Increased incidence of acute myeloid leukemia after liver transplantation? Description of three new cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Molecular pathogenesis of secondary acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Modern approaches to treating acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Arsenic trioxide for management of acute promyelocytic leukemia: current evidence on its role in front-line therapy and recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

A PMLRARalpha transgene initiates murine acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0625-5

15/17 chromosome translocation in acute promyelocytic leukemia

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia

1 reference

12 December 2020

1 reference

12 December 2020

Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease

1 reference

12 December 2020

BRCA2 mutation and the risk of hematologic malignancy

1 reference

12 December 2020

Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis

1 reference

12 December 2020

A case of myelocytic leukemia simulating the mouse model diseases

1 reference

12 December 2020

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups

1 reference

12 December 2020

Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences

1 reference

12 December 2020

Acute promyelocytic leukemia with t(15;17) following inhibition of DNA topoisomerase II

1 reference

12 December 2020

Bone marrow doses and leukaemia risk in radiotherapy of prostate cancer

1 reference

12 December 2020

10.1007/S12032-013-0625-5

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1006424637

0 references

1 reference